Healthcare - Biotechnology - NASDAQ - US
$ 3.07
-11.5 %
$ 27.4 M
Market Cap
-2.67
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
125.51%
EBIT
Estimate
--37.58%
Net Income
Estimate
13.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Marker Therapeutics, Inc.
MRKR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart MRKR
EBIT FORECAST
EBIT Forecast Chart MRKR
NET INCOME FORECAST
Net Income Chart MRKR